Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance

CONTEXT: Glucagon-like peptide-1 (GLP-1) agonists control postprandial glucose and lipid excursion in type 2 diabetes; however, the mechanisms are unclear. OBJECTIVE: To determine the mechanisms of postprandial lipid and glucose control with lixisenatide (GLP-1 analog) in type 2 diabetes. DESIGN: Ra...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Endocrinol Metab
Egile Nagusiak: Whyte, Martin B, Shojaee-Moradie, Fariba, Sharaf, Sharaf E, Jackson, Nicola C, Fielding, Barbara, Hovorka, Roman, Mendis, Jeewaka, Russell-Jones, David, Umpleby, A Margot
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Endocrine Society 2018
Gaiak:
Clinical Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6300412/
https://ncbi.nlm.nih.gov/pubmed/30215735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2018-01176
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak